The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravisMartin Skov, Thomas Holm Pedersen, Jeanette J. Morgen et al.|Science Translational Medicine|2024Cited by 31
Role of recovery of acetylcholine release in compromised neuromuscular junction functionJeppe Blichfeldt Winther, Thomas Holm Pedersen, Jeanette J. Morgen et al.|Neuromuscular Disorders|2024Cited by 4
ClC-1 Inhibition as a Mechanism for Accelerating Skeletal Muscle Recovery After Neuromuscular Block in RatsMarianne Skals, Thomas Holm Pedersen, Martin Broch‐Lips et al.|Nature Communications|2024Cited by 4
ClC-1 Inhibition as a Novel Mechanism for Accelerating Recovery of Skeletal Muscle Function After Neuromuscular Block in an Experimental Rat ModelThomas Holm Pedersen, Hans D. de Boer, Marianne Skals et al.|Research Square|2024Cited by 0